Viewing StudyNCT00246298



Ignite Creation Date: 2024-05-05 @ 12:07 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00246298
Status: TERMINATED
Last Update Posted: 2011-06-10
First Post: 2005-10-28

Brief Title: A Study to Assess the Effectiveness of PROCRIT Epoetin Alfa Dosing Every 2 Weeks Versus Once a Week in Anemic HIV-infected Patients
Sponsor: Johnson Johnson Pharmaceutical Research Development LLC
Organization: Johnson Johnson Pharmaceutical Research Development LLC

Conditions & Keywords Data

Conditions:
Name
Anemia
HIV
Keywords:
Name View
AIDS View
Anemia View
erythropoetin View
Epoetin alfa View
erythropoietin recombinant View
HIV infection View
HIV View